 BOSTON, MASSACHUSETTS, Dec. 14, 2022 GLOBE NEWSWIRE BIOXYTRAN, INC. OTCQB: BIXT the Company, a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases announced that it has established an Indian subsidiary Pharmalectin India Private Limited. The purpose of the subsidiary is to launch commercial product sales ... The post Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization appeared first on F... 